Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sabesp

20.32
+0.30001.50%
Volume:1.57M
Turnover:31.57M
Market Cap:13.89B
PE:8.97
High:20.49
Open:19.89
Low:19.55
Close:20.02
Loading ...

SBS Holdings Inc Sees 1H Net Y3.20B

Dow Jones
·
7 hours ago

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

Press Release: Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

Dow Jones
·
10 May

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP expected to post earnings of R$2.20 a share - Earnings Preview

Reuters
·
10 May

SABESP Releases 2024 Financial Statements with Strong Asset Base

TIPRANKS
·
07 May

Press Release: Standard BioTools Reports First Quarter 2025 Financial Results

Dow Jones
·
07 May

Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients

ACCESS Newswire
·
30 Apr

Here's Why We're Wary Of Buying SBS Transit's (SGX:S61) For Its Upcoming Dividend

Simply Wall St.
·
30 Apr

SABESP Updates Bylaws to Strengthen Governance

TIPRANKS
·
30 Apr

Is Evergy (EVRG) Stock Outpacing Its Utilities Peers This Year?

Zacks
·
29 Apr

Jaguar Health to Present Initial Results from the Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) During an April 30 Investor Webcast

ACCESS Newswire
·
28 Apr

Big Money Buys SABESP

FX Empire
·
25 Apr

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Business Wire
·
23 Apr

Zacks.com featured highlights include Allot, Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP, Lindsay, Equity Bancshares and Griffon

Zacks
·
21 Apr

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress

ACCESS Newswire
·
17 Apr

5 Must-Buy Efficient Stocks Amid Volatile Market Conditions

Zacks
·
17 Apr

SBS Transit Engages Shareholders Ahead of Annual General Meeting

TIPRANKS
·
17 Apr

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Business Wire
·
14 Apr

Is Energias de Portugal (EDPFY) Outperforming Other Utilities Stocks This Year?

Zacks
·
11 Apr

SBS Transit (SGX:S61) Has Announced That It Will Be Increasing Its Dividend To SGD0.231

Simply Wall St.
·
08 Apr